Search - tctmd.com

Displaying 561 - 580 of 671

Sort: Relevancy | Date

Presentation

Benefit of Bivalirudin Versus Heparin After Transradial and Transfemoral PCI

Presenter: J. MacHaalany

October 11, 2012

Presentation

Bleeding with Aspirin vs. Apixaban in Patients with A-fib Unsuitable for Warfarin: The AVERROES Trial

Presenter: Greg C. Flaker

October 09, 2012

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

Presentation

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Presenter: Christoph Varenhorst

September 26, 2012

Presentation

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Presenter: B-K Kim

September 19, 2012

Presentation

Double Antiplatelet Therapy After DES Implantation

Presenter: I. Ferreira-Gonz?lez

September 19, 2012

Presentation

Impact of Clopidogrel Loading Dose in Patients with CKD Undergoing Primary PCI for STEMI

Presenter: 56196|JY Kim

September 14, 2012

Presentation

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

Presenter: 89964|William Baker

September 10, 2012

Presentation

Association of Clopidogrel Treatment with Risk of Mortality and Cardiovascular Events Following MI in Patients With and Without Diabetes

Presenter: Charlotte Andersson

September 06, 2012

Presentation ESC 2012

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Presenter: Willem Dewilde

August 28, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

Presentation ESC 2012

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

Presenter: 159942|Jolanta Siller-Matula

August 26, 2012

Presentation

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Presenter: Thomas Cuisset

August 17, 2012

Presentation ACVS 2012

Which Antiplatelets to Use for PCI?

Presenter: Dev Pahlajani

August 04, 2012

Presentation ACVS 2012

Peri-Operative Medical Management of Patient with Recurrent Ischemia

Presenter: Ravi Kumar Aluri

August 03, 2012

Presentation ACVS 2012

Bivalirudin Versus Heparin in STEMI

Presenter: Colonel Anil Dhall

August 03, 2012

Presentation

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Presenter: Jan H. Cornel

August 02, 2012

Presentation

Pantoprazole Significantly Interferes with Antiplatelet Effect of Clopidogrel

Presenter: Maria Serena Parri

July 31, 2012

Presentation

Clopidogrel Discontinuation After Myocardial Infarction and Risk of Thrombosis

Presenter: Mette Charlot

July 19, 2012

Presentation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Presenter: Ryota Sakurai

July 12, 2012

Advertisement

Benefit of Bivalirudin Versus Heparin After Transradial and Transfemoral PCI

Bleeding with Aspirin vs. Apixaban in Patients with A-fib Unsuitable for Warfarin: The AVERROES Trial

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Double Antiplatelet Therapy After DES Implantation

Impact of Clopidogrel Loading Dose in Patients with CKD Undergoing Primary PCI for STEMI

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

Association of Clopidogrel Treatment with Risk of Mortality and Cardiovascular Events Following MI in Patients With and Without Diabetes

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Which Antiplatelets to Use for PCI?

Peri-Operative Medical Management of Patient with Recurrent Ischemia

Bivalirudin Versus Heparin in STEMI

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Pantoprazole Significantly Interferes with Antiplatelet Effect of Clopidogrel

Clopidogrel Discontinuation After Myocardial Infarction and Risk of Thrombosis

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content